Birdwatch Archive

Birdwatch Note

2023-03-15 20:23:22 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf

Written by 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E
Participant Details

All Information

• ID - 1636100800689627137
• noteId - 1636100800689627137
• participantId -
• noteAuthorParticipantId - 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E Participant Details
• createdAtMillis - 1678911802824
• tweetId - 1636091934799167497
• classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
• believable -
• harmful -
• validationDifficulty -
• misleadingOther - 0
• misleadingFactualError - 1
• misleadingManipulatedMedia - 0
• misleadingOutdatedInformation - 0
• misleadingMissingImportantContext - 0
• misleadingUnverifiedClaimAsFact - 0
• misleadingSatire - 0
• notMisleadingOther - 0
• notMisleadingFactuallyCorrect - 0
• notMisleadingOutdatedButNotWhenWritten - 0
• notMisleadingClearlySatire - 0
• notMisleadingPersonalOpinion - 0
• trustworthySources - 1
• summary
• From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf